Titan Pharmaceuticals, Inc.(NASDAQ : TTNP)
(
)
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Message Boards
...
News
...
Health Technology » Pharmaceuticals Major
Company Profile
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.